Non-profit to accelerate development of potential new Parkinson's drug

(Parkinson's UK) UK charity, Parkinson's UK is partnering with US biotech Neurolixis in a $1 million deal to accelerate the development of a potential cure for dyskinesia -- a severe side effect of common Parkinson's medication.

from EurekAlert! - Social and Behavioral Science http://ift.tt/2Gcheof